Open Access Mandates in 2026: What Researchers Actually Need to Do
Open access policy is now a workflow problem, not a side note for the acknowledgments section. If you wait until acceptance to think about compliance, you often limit your journal options too late.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Open access mandates used to feel like something authors could deal with after acceptance. In 2026, that is often too late. The policy environment is now concrete enough that your funder, your target journal, and your repository route can shape each other before submission.
If you do not check that triangle early, you can end up choosing a journal you cannot easily comply with.
Short answer
In 2026, the most important open-access mandate facts for many funded researchers are:
- the 2024 NIH Public Access Policy is already in effect for manuscripts accepted on or after July 1, 2025
- UKRI still allows immediate compliance through either open-access publishing or immediate repository deposit without embargo
- Plan S continues to push for full and immediate open access through compliant journals, platforms, or repositories
- ERC / Horizon Europe rules require open access through trusted repositories and make publication-venue choice matter earlier than many authors assume
The practical lesson is simple: check compliance before you pick the journal, not after the acceptance letter.
Why this matters more in 2026 than it did a few years ago
Open access mandates have become more operational and less theoretical. They now affect:
- what licence you need
- whether embargo is allowed
- whether the accepted manuscript can be deposited immediately
- whether APC funding is reimbursable
- whether a repository counts as compliant
That means policy is no longer a final-stage administrative detail. It is a submission constraint.
The policy landscape at a glance
Funder or framework | Core requirement in 2026 | Key author takeaway |
|---|---|---|
NIH | Accepted manuscripts covered by the 2024 policy must go to PubMed Central upon acceptance and be public without embargo on publication date | NIH compliance starts at acceptance, not months later |
UKRI | Immediate open access via journal route or repository route, no embargo | Repository deposit remains a real compliance path |
Plan S funders | Full and immediate open access via compliant journal, platform, or repository | Delay and restrictive licensing are the main problems |
ERC / Horizon Europe | Open access and trusted repository requirements apply, with repository and funding-route details mattering | Venue choice and repository planning should happen early |
That table is only a starting point. The important part is how the differences affect actual journal decisions.
NIH in 2026: the biggest operational shift many researchers still miss
The NIH change is not speculative anymore. It is already live.
Official NIH policy pages state that the 2024 NIH Public Access Policy went into effect on July 1, 2025. For manuscripts accepted on or after that date:
- the Author Accepted Manuscript must be submitted to PubMed Central upon acceptance for publication
- public availability must occur without embargo on the official publication date
This is a big workflow shift because it compresses timing.
Under the older mental model, authors often assumed there was more room for delayed compliance. In the current NIH framework, the accepted manuscript and rights situation need to be thought about much earlier.
What authors should do differently for NIH-funded work
- check whether the journal allows the accepted manuscript route cleanly
- make sure author agreements do not block PMC deposit timing
- coordinate with your institution early if rights or licensing language is complicated
- do not assume an embargoed subscription workflow will remain easy to reconcile
If your manuscript acknowledges NIH funding, this is no longer a minor afterthought.
UKRI in 2026: still more flexible than many authors realize
UKRI's open access policy remains one of the clearer systems because it gives authors two routes.
UKRI's official guidance states that for in-scope peer-reviewed research articles submitted on or after April 1, 2022, authors can comply either by:
- publishing the article open access in the journal or platform
- publishing in a subscription journal and depositing the Author Accepted Manuscript in an institutional or subject repository at final publication with a permitted licence and no embargo
That second route matters a lot.
Many authors still assume compliance means paying an APC. Under UKRI, repository deposit can still be a valid route when the journal setup permits it.
What authors should actually check under UKRI
- whether the journal allows immediate repository deposit at publication
- what licence is required, usually CC BY or another permitted licence
- whether your institutional open access team already has a compliant pathway
- whether the article type is in scope
The practical consequence is that some subscription journals remain usable for UKRI-funded work, but only if the repository route is genuinely compliant.
Plan S in 2026: still about immediacy, not delay
Plan S is sometimes discussed like a historical milestone rather than a live policy frame. That is a mistake.
Official cOAlition S materials continue to define the core principle in straightforward terms: funded scholarly publications should be openly available immediately, either through compliant open-access journals or platforms, or through immediate repository availability without embargo.
Plan S materials also continue to emphasize:
- author or institutional rights retention
- open licensing, preferably CC BY
- repository compliance where repository routes are used
The exact implementation varies by funder, but the practical spirit remains the same:
delay is the enemy, and rights matter.
What authors often misunderstand about Plan S
They think it only applies if they publish in a fully open-access journal.
That is not the whole picture. Plan S guidance explicitly recognizes multiple compliant routes, including repository-based routes when immediate open access requirements are met. The harder issue is not whether there is one route. It is whether your chosen journal actually supports a compliant one.
ERC and Horizon Europe in 2026
ERC and broader Horizon Europe obligations are often harder for authors to interpret because they live inside grant-agreement logic rather than a single short policy page.
Current ERC open-science guidance and scientific reporting materials point to several relevant realities:
- peer-reviewed publications must be made open access
- accepted manuscripts or published versions should be deposited in an open-access repository
- under Horizon Europe, repositories must be trusted
- ERC guidance also notes that for Horizon Europe projects, only fees for full open-access publication venues are reimbursable as direct costs from the ERC grant
This matters because authors sometimes assume hybrid payment and full compliance are interchangeable in all grant environments. They are not.
What authors funded through ERC or Horizon Europe should do
- verify the repository route early
- check whether the journal's route fits trusted-repository expectations
- confirm whether APC reimbursement assumptions are actually valid for that venue
- make sure metadata and funding acknowledgments are repository-ready
In practice, ERC and Horizon Europe compliance often turns into a venue-selection problem earlier than authors expect.
The most common compliance mistake
Authors choose the journal first, then ask whether compliance is possible.
That is backwards.
A better order is:
- identify your funder's actual current requirements
- short-list journals with a clearly compliant route
- then decide among those journals on fit, ambition, and manuscript readiness
This sequence is especially important if the paper is close to the border between a hybrid subscription venue and a fully open route.
How open-access mandates intersect with journal choice
This is where metrics and prestige can mislead.
A journal may have:
- strong citation metrics
- excellent prestige signaling
- the right audience
and still be a poor compliance choice if:
- embargo is incompatible with your funder
- the licence is too restrictive
- repository deposit timing fails policy requirements
- APC reimbursement assumptions do not hold
That is why journal metrics explained: impact factor vs SJR vs CiteScore should always be read alongside policy and rights reality, not instead of it.
A practical compliance checklist before submission
Use this checklist before you commit to a journal.
1. Which policy applies?
- NIH?
- UKRI?
- a Plan S funder?
- ERC / Horizon Europe?
- more than one?
Mixed-funder papers need the strictest workable path, not the most convenient one.
2. What date matters?
Some policies key off:
- submission date
- acceptance date
- publication date
For NIH, the acceptance date is especially important under the 2024 policy.
3. Which version can you deposit?
- Author Accepted Manuscript?
- Version of Record?
- both?
Do not assume the answer is obvious from the journal homepage.
4. What licence is required?
If your funder or framework expects CC BY or a similarly open route, make sure the journal or repository pathway supports it.
5. Is there an embargo?
If your policy requires immediate open access, an embargoed repository pathway is not good enough.
6. Who pays, if anyone?
If you are assuming APC support:
- confirm that funding exists
- confirm that the venue type is eligible
- confirm that the route is compliant, not just billable
Where authors should get help
Do not do this alone if the paper matters.
Good support often comes from:
- your university library or scholarly communications office
- institutional open-access teams
- grant administrators
- repository managers
And on the manuscript side, submission readiness checklist and a Manusights AI Review help with the separate question that policy does not answer: whether the paper is actually ready for the journal you are trying to make compliant.
What open access mandates do not tell you
This is worth stating plainly.
Open access compliance tells you nothing direct about:
- whether the journal is a good scientific fit
- whether the evidence bar is right for your paper
- whether reviewers will think the claims are overstated
- whether the submission is strategically timed well
That is why compliance should be treated as one gate, not the only gate.
My bottom line
Open access mandates in 2026 are now concrete enough that researchers should treat them as submission-planning inputs, not post-acceptance cleanup.
The big practical moves are:
- know whether NIH, UKRI, Plan S, or ERC-style rules apply
- check acceptance-date and embargo logic early
- verify the repository and licence route before choosing the journal
- separate compliance from manuscript quality
Compliance gets the paper through policy. It does not get the paper through review.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.